This is the latest episode of the free DDW narrated podcast, titled “Innovative approaches to improving drug discovery”, which covers three articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: Post-Covid cognitive impairment: a new target for drug development?, Sitting Down With Dr Harren Jhoti, Astex Pharmaceuticals, and The Nobel Prize winning power of click chemistry.

In the first article, Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne, and Dr Jenny Barnett explore the effects of long Covid symptoms and what the opportunities are for drug developers working to treat post-Covid cognitive impairment.

In the second article, Dr Harren Jhoti speaks to Diana Spencer after receiving his OBE, about his career, the UK life sciences sector, fragment-based drug discovery and what the future holds for the industry.

In the third article, José Mejía Oneto, PhD, Founder and CEO at Shasqi, discusses the potential of chemistry to engineer biology to improve the effectiveness of human therapeutics and revolutionise the treatment of disease.